The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing

Autor:	Paul R. Ingram, Davild J. Speers, Timothy J. J. Inglis, Gerald B. Harnett, Lyn C. O'Reilly, Paul E. Healy, Michael J. Leung, Namraj Goire
Rok vydání:	2016
Předmět:	0301 basic medicine Microbiology (medical) Susceptibility testing Carbapenemase-Producing Enterobacteriaceae 030106 microbiology Pcr assay Microbial Sensitivity Tests Biology Polymerase Chain Reaction Microbiology Meropenem beta-Lactamases Bacterial protein 03 medical and health sciences Bacterial Proteins Enterobacteriaceae medicine Humans Temocillin Molecular Biology Enzyme Assays GeneXpert MTB/RIF Enterobacteriaceae Infections biology.organism_classification Virology Anti-Bacterial Agents Thienamycins medicine.drug
Zdroj:	Journal of Microbiological Methods. 124:10-12
ISSN:	0167-7012
DOI:	10.1016/j.mimet.2016.03.001
Popis:	A local predominance of carbapenemase producing Enterobacteriaceae with low minimum inhibitory concentrations (MIC) to meropenem prompted a review of methods available for carbapenemase detection. We report on results using two selective media, temocillin discs, CarbaNP test, GeneXpert Carba-R assay and an in-house PCR assay.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c974dff8380200bc1154b20d73f361cd https://doi.org/10.1016/j.mimet.2016.03.001 Zobrazit plný text záznamu Full Text from ScienceDirect